Your browser doesn't support javascript.
loading
Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease.
Pedamallu, Chandra Sekhar; Bhatt, Ami S; Bullman, Susan; Fowler, Sharyle; Freeman, Samuel S; Durand, Jacqueline; Jung, Joonil; Duke, Fujiko; Manzo, Veronica; Cai, Diana; Ananthakrishnan, Ashwin; Ojesina, Akinyemi I; Ramachandran, Aruna; Gevers, Dirk; Xavier, Ramnik J; Bhan, Atul K; Meyerson, Matthew; Yajnik, Vijay.
Afiliação
  • Pedamallu CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Harvard Medical School, Boston, Massachusetts.
  • Bhatt AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Bullman S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Fowler S; Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Freeman SS; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Durand J; Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Jung J; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Duke F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Manzo V; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Cai D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Ananthakrishnan A; Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Ojesina AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Ramachandran A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Gevers D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Xavier RJ; Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Bhan AK; Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Harvard Medical School, Boston, Massachusetts.
  • Yajnik V; Crohn's and Colitis Center, Massachusetts General Hospital, Boston, Massachusetts.
Cell Mol Gastroenterol Hepatol ; 2(5): 563-566.e5, 2016 Sep.
Article em En | MEDLINE | ID: mdl-28174737
ABSTRACT
BACKGROUND &

AIMS:

Microbial dysbiosis and aberrant host-microbe interactions in the gut are believed to contribute to the development and progression of Crohn's disease (CD). Microbiome studies in CD typically have focused on microbiota in feces or superficial mucosal layers of the colon because accessing DNA from deeper layers of the bowel is challenging. In this study, we analyzed the deep tissue microbiome in patients who underwent surgical resection of the small intestine.

METHODS:

Paraffin blocks were obtained from 12 CD patients undergoing ileocecal resection, and healthy ileum samples (inflammatory bowel disease-free controls) were obtained from 12 patients undergoing surgery for right-sided colon cancer. Diseased and healthy-appearing ileum was identified using microscopy, and paraffin blocks were macrodissected using a core needle to specifically isolate DNA. Illumina Whole Genome Sequencing was used for microbial sequence identification and subsequent taxonomic classification using the PathSeq tool.

RESULTS:

We observed significant differences between the microbiome of CD samples vs inflammatory bowel disease-free controls, including depletion of Bacteroidetes and Clostridia. Notably, microbial composition at the phyla level did not differ markedly between healthy and diseased areas of CD patients. However, we observed enrichment of potentially pathogenic organisms at the species level.

CONCLUSIONS:

Our study showed dysbiosis within deeper layers of the ileum of CD patients, specifically enrichment of enterotoxigenic Staphylococcus aureus and an environmental Mycobacterium species not described previously. Future studies with larger cohort sizes are warranted to confirm these findings. Studies would benefit from effective microbial DNA extraction methods from paraffin sections and host nucleic acid depletion approaches to increase microbial read coverage.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article